diltiazem has been researched along with alprostadil in 17 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (5.88) | 18.7374 |
| 1990's | 9 (52.94) | 18.2507 |
| 2000's | 2 (11.76) | 29.6817 |
| 2010's | 5 (29.41) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
| Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Bellman, K; Knegtel, RM; Settimo, L | 1 |
| Finn, JC; Pearl, RG | 1 |
| Francis, GS; Johnson, GJ; Leis, LA | 1 |
| Miwa, K; Toda, N | 1 |
| Kawashima, A; Koike, H; Nishio, S; Ueno, Y | 1 |
| Hibi, M; Iwase, J; Kawamura, M; Murakami, F; Usui, A; Yoshida, K | 1 |
| Fukasawa, M; Fukui, K; Hirooka, S; Kohi, M; Orita, H; Uchino, H; Washio, M | 2 |
| Reinecke, P; Sandmann, W; Szabo, Z; Torsello, G | 1 |
| Kojima, M; Miyakawa, T; Ui, M | 1 |
| Kusumoto, K; Notodihardjo, HW; Ogawa, Y | 1 |
| Az-Ma, T; Saeki, N; Yuge, O | 1 |
17 other study(ies) available for diltiazem and alprostadil
| Article | Year |
|---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding | 2012 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Comparison of the accuracy of experimental and predicted pKa values of basic and acidic compounds.
Topics: Chemistry, Pharmaceutical; Forecasting; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Random Allocation | 2014 |
Hemodynamic effects of diltiazem during vasoconstrictor pulmonary hypertension in sheep.
Topics: Alprostadil; Animals; Diltiazem; Hemodynamics; Hypertension, Pulmonary; Male; Nifedipine; Sheep; Vasodilator Agents | 1990 |
Adenosine potentiates the inhibitory effects of calcium channel antagonists on human platelet aggregation induced by thromboxane A2 or U46619.
Topics: Adenosine; Alprostadil; Calcium Channel Blockers; Diltiazem; Drug Synergism; Epinephrine; Humans; In Vitro Techniques; Nifedipine; Platelet Aggregation Inhibitors; Prostaglandin Endoperoxides, Synthetic; Thromboxane A2; Verapamil | 1990 |
The regional difference of relaxations induced by various vasodilators in isolated dog coronary and mesenteric arteries.
Topics: Adenosine; Alprostadil; Animals; Coronary Vessels; Diltiazem; Dogs; Epoprostenol; Female; In Vitro Techniques; Male; Mesenteric Arteries; Muscle Relaxation; Muscle, Smooth, Vascular; Nitroglycerin; Nitroprusside; Thromboxane A2; Vasodilator Agents | 1985 |
Effect of beraprost sodium, a stable prostacyclin analogue, on pulmonary thromboembolism in mice.
Topics: Administration, Oral; Alprostadil; Animals; Aspirin; Bridged Bicyclo Compounds; Collagen; Diltiazem; Drug Evaluation, Preclinical; Epinephrine; Epoprostenol; Fatty Acids, Monounsaturated; Fibrinolytic Agents; Heparin; Hydralazine; Injections, Intravenous; Isosorbide Dinitrate; Male; Mice; Nifedipine; Nitroprusside; Platelet Aggregation Inhibitors; Pulmonary Embolism; Superoxide Dismutase; Vasodilator Agents | 1995 |
The effects of calcium antagonists and prostaglandin E1 on isolated canine coronary arterial tension.
Topics: Alprostadil; Animals; Calcium; Calcium Channel Blockers; Coronary Vessels; Data Interpretation, Statistical; Diltiazem; Dogs; In Vitro Techniques; Muscle Contraction; Muscle, Smooth, Vascular; Nicardipine; Nifedipine; Potassium; Sodium; Solutions; Verapamil | 1994 |
In vitro evaluation of nicorandil, diltiazem, and prostaglandin E1 on hypothermic injury to immature myocytes.
Topics: Alprostadil; Animals; Animals, Newborn; Cell Death; Cells, Cultured; Cold Temperature; Creatine Kinase; Diltiazem; Female; Heart Rate; Heart Ventricles; L-Lactate Dehydrogenase; Myocardium; Niacinamide; Nicorandil; Rats; Rats, Wistar; Ventricular Function | 1995 |
Cytoprotective effects of nicorandil on hypothermic injury to immature cardiac myocytes--comparison with nitroglycerin, diltiazem and prostaglandin E1.
Topics: Alprostadil; Animals; Cells, Cultured; Cold Temperature; Creatine Kinase; Cryopreservation; Cryoprotective Agents; Diltiazem; Heart; L-Lactate Dehydrogenase; Myocardium; Niacinamide; Nicorandil; Nitroglycerin; Rats; Vasodilator Agents | 1994 |
[The role of pharmacologic kidney protection in preventing post-ischemic renal failure in animal experiment].
Topics: Acute Kidney Injury; Alprostadil; Animals; Creatinine; Diltiazem; Dogs; Drug Therapy, Combination; Ischemia; Kidney; Kidney Function Tests; Renal Circulation; Superoxide Dismutase; Vascular Resistance; Water-Electrolyte Balance | 1993 |
Differential routes of Ca2+ influx in Swiss 3T3 fibroblasts in response to receptor stimulation.
Topics: 3T3 Cells; Alprostadil; Angiotensin II; Animals; Arachidonic Acid; Bombesin; Bradykinin; Calcium; Calcium Channel Blockers; Diltiazem; Endothelins; Enzyme Activation; GTP-Binding Proteins; Inositol Phosphates; Mice; Nifedipine; Pertussis Toxin; Phospholipases A; Phospholipases A2; Platelet-Derived Growth Factor; Protein Kinase C; Receptors, Cell Surface; Tetradecanoylphorbol Acetate; Thapsigargin; Thrombin; Vasopressins; Virulence Factors, Bordetella | 1998 |
The blood flow patterns of microsurgical procedures in rats with topical and systemic vasodilators.
Topics: Administration, Topical; Alprostadil; Analysis of Variance; Anastomosis, Surgical; Anesthetics, Local; Animals; Chlorpromazine; Diltiazem; Dopamine Antagonists; Femoral Artery; Laser-Doppler Flowmetry; Lidocaine; Male; Microsurgery; Rats; Rats, Wistar; Regional Blood Flow; Vasodilator Agents | 1998 |
Differential action of spasmolytic vasodilators on platelet aggregation and endothelial cell-dependent anti-aggregation.
Topics: Alprostadil; Animals; Aorta; Cells, Cultured; Diltiazem; Dose-Response Relationship, Drug; Endothelium, Vascular; Nicardipine; Nitroglycerin; Nitroprusside; Papaverine; Pentobarbital; Platelet Aggregation; Platelet Aggregation Inhibitors; Swine; Sympatholytics; Vasodilator Agents | 2000 |